SEC
RETA

Seven Eight Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Seven Eight Capital’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,700
Closed -$245K – 604
2020
Q1 		$245K Buy
+1,700
New +$245K 0.06% 363